Topics
Innovation
Laser
Medical
Practice
Research
Surgical
Training
View Issue
Sponsored by Orasis Pharmaceuticals
View Insert
Sponsored By Allergan, an AbbVie company
View Supplement
In This Issue
Arsham Sheybani, MD
What’s the next step for the management of primary open-angle glaucoma?
Sandra Johnson, MD, and Sabrina Khalil, MD
What is the next step when glaucoma is progressing and IOP is elevated after laser trabeculoplasty?
Steven R. Sarkisian Jr, MD; Sahar Bedrood, MD, PhD; Nathan M. Radcliffe, MD; and Manjool Shah, MD
Laser treatment efficacy and central corneal thickness in patients with ocular hypertension.
Lauren S. Blieden, MD, and Junru Yan, BA
It’s important, and it’s easier than you think.
Lynn W. Sun, MD, PhD
OCT progression analysis can help to identify early structural changes and facilitate a proactive approach to treatment.
Ahmet Akman, MD, FACS
Two novel devices expand the options for surgical glaucoma treatment on a global level.
Ahmad A. Aref, MD, MBA
Allisa Song, BS
How the sausage is made: an inside look at clinical trials from the patient perspective.
Richie Kahn, MPH
Allyship is an active process through which individuals help address equity and inclusion by acquiring knowledge and learning to understand their own privilege and enhance the success of others.
Lynn K. Gordon, MD, PhD
Examining the state of diversity in ophthalmology and how to build a more inclusive field.
Leon W. Herndon, MD; Constance Okeke, MD, MSCE; Gloria P. Fleming, MD; Mildred M.G. Olivier, MD; Zaiba Malik, MD; and Eve Higginbotham, SM, MD, ML
Gender parity is an increasingly prioritized issue in the field of medicine.
Sunidhi Ramesh, BS; Lama Al-Aswad, MD, MPH; and Aakriti Garg Shukla, MD
Why action is necessary to improve diversity, equity, and inclusion.
Paul P. Lee, MD, JD
Subscribe
Stay up to date all on all things Glaucoma by signing up to receive our print publication or subscribe to our email alerts.